Cargando…

Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney

The knowledge of each patient's global risk profile is a prerequisite for effective therapeutic strategies in primary hypertension. Detecting the presence of subclinical organ damage at the cardiac, vascular, and renal levels is key for stratifying cardiovascular risk and may also be helpful in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Viazzi, Francesca, Leoncini, Giovanna, Pontremoli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745834/ https://www.ncbi.nlm.nih.gov/pubmed/23984048 http://dx.doi.org/10.1155/2013/542646

Ejemplares similares

Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient
por: Viazzi, Francesca, et al.
Publicado: (2014)

Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013)

Serum Uric Acid Levels Predict New-Onset Type 2 Diabetes in Hospitalized Patients With Primary Hypertension: The MAGIC Study
por: Viazzi, Francesca, et al.
Publicado: (2011)

Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age
por: Russo, Elisa, et al.
Publicado: (2020)

Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components
por: Russo, Elisa, et al.
Publicado: (2023)

Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
por: Leoncini, Giovanna, et al.
Publicado: (2020)

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019)

Chronic kidney disease as a predictor of clinical risk in the elderly
por: Viazzi, Francesca, et al.
Publicado: (2016)

SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits
por: Leoncini, Giovanna, et al.
Publicado: (2021)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
por: Russo, Elisa, et al.
Publicado: (2021)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology
por: Pontremoli, Roberto, et al.
Publicado: (2020)

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
por: Mirijello, Antonio, et al.
Publicado: (2018)

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
por: Viazzi, Francesca, et al.
Publicado: (2017)

Diabetic kidney disease in the elderly: prevalence and clinical correlates
por: Russo, Giuseppina T., et al.
Publicado: (2018)

Normoalbuminuric kidney impairment in patients with T1DM: insights from annals initiative
por: Lamacchia, Olga, et al.
Publicado: (2018)

Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2017)

Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative
por: Piscitelli, Pamela, et al.
Publicado: (2018)

Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function
por: Gentile, Sandro, et al.
Publicado: (2017)

Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative
por: De Cosmo, Salvatore, et al.
Publicado: (2016)

Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4
por: Verzola, Daniela, et al.
Publicado: (2014)

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
por: Kielstein, Jan T., et al.
Publicado: (2020)

Metabolic syndrome, serum uric acid and renal risk in patients with T2D
por: Viazzi, Francesca, et al.
Publicado: (2017)

Role of Uric Acid in Vascular Remodeling: Cytoskeleton Changes and Migration in VSMCs
por: Russo, Elisa, et al.
Publicado: (2023)

Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
por: Okpechi, Ikechi G, et al.
Publicado: (2010)

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project
por: Russo, Elisa, et al.
Publicado: (2021)

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514–519
por: Ceriello, Antonio, et al.
Publicado: (2020)

Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
por: Collins, Dylan R J, et al.
Publicado: (2017)

HEARTS in the Americas: innovations for improving hypertension and cardiovascular disease risk management in primary care
por: Ordunez, Pedro, et al.
Publicado: (2022)

Hypertension Management in the High Cardiovascular Risk Population
por: Maraj, Ilir, et al.
Publicado: (2013)

Sugar, fructose, uric acid and hypertension in children and adolescents
por: Viazzi, Francesca, et al.
Publicado: (2015)

Role of Biomarkers in the Diagnosis, Risk Assessment, and Management of Pulmonary Hypertension
por: Rameh, Vanessa, et al.
Publicado: (2016)

The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care
por: Ordunez, Pedro, et al.
Publicado: (2022)

Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors
por: Tuñón, José, et al.
Publicado: (2007)

From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial
por: Mortsiefer, Achim, et al.
Publicado: (2015)

Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
por: Poznyak, Anastasia V., et al.
Publicado: (2022)

Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2022)

The Role of Cardiovascular Risk Assessment in Preventive Medicine: A Perspective from Portugal Primary Health-Care Cardiovascular Risk Assessment
por: Santos, Paulo
Publicado: (2020)

Cardiovascular Risk Assessment in Primary Osteoporosis
por: Armstrong, DJ, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_otnvmn1akf88e7h13uq7p173ej